Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00498303 | Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008 | PHASE3 | COMPLETED | 120 | — | — | Jun 1, 2007 | - | Apr 22, 2008 | 1 | Germany |
| Name | Type | Description |
|---|---|---|
| trivalent split influenza vaccine | BIOLOGICAL | - |
Inclusion Criteria: * ≥ 18 years of age, mentally competent, willing and able to give informed consent prior to study entry * available for all the visits scheduled in the study and able to comply with all study requirements * in good health as determined by: medical history, physical examination, ...